Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-29

Clinical Trial Update: Performance of PET 18 F-FDG Coupled to CT With Contrast Injection Iodized in the Diagnosis of Early Recurrences of Head and Neck Carcinoma Treated With Concurrent Chemoradiation. Comparison With 18F-FDG PET Coupled With CT Not Injected With Filling CT Standard Injection [NA]

View source ↗

Summary

This completed clinical trial compared PET/CT imaging with iodinated contrast versus PET/CT without contrast for detecting early recurrences of head and neck sq…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 18F-FDG (Fluorodeoxyglucose F-18) (Fluorodeoxyglucose F-18)
  • Iodinated contrast agent (Iodinated contrast agent)

Snippet

Sponsor: University Hospital, Caen | Conditions: Squamous Cell Carcinoma of the Head and Neck | NA | Status: COMPLETED